Navigation Links
Creabilis Awarded Prestigious European Commission FP7 Grant to Further Develop its LSE 'Topical-by-Design' Technology
Date:4/23/2013

LUXEMBOURG, April 23, 2013 /PRNewswire/ --

Creabilis SA, a late clinical stage European biotechnology company specialising in the development of treatments in dermatology, for inflammation and pain, today announces that it has been awarded a prestigious European Union Framework Programme 7 (FP7) grant in the 'Health: Systems Medicine' work programme theme. The €1.98m FP7 grant will be used to develop the next generation of Creabilis' 'topical-by-design' pre-clinical candidates to complement its existing clinical portfolio. The candidates will be developed using Creabilis' proprietary Low Systemic Exposure (LSE) technology.

Creabilis' LSE technology creates novel drugs that combine high efficacy with a favourable safety profile to be delivered topically. LSE generates innovative molecules with unique physico-chemical and pharmacological characteristics, combining high local concentration with low systemic absorption. This technology has already been clinically validated through CT327, Creabilis' lead compound that is currently in late stage clinical development for diseases of dermatology.

FP7 is the European Union's main instrument for supporting innovative research in Europe, and has two main strategic objectives:

  • to strengthen the scientific and technological base of European industry
  • to encourage its international competitiveness, while promoting research that supports EU policies

The FP7 grant has been awarded on the basis of a highly competitive, two-stage, peer-review process, and the award is a validation of our LSE technology.

Creabilis will be leading a pan-European consortium to help develop the next generation of LSE candidates using a novel systems biology and network pharmacology approach. The FP7 project combines Creabilis' experience and expertise with that of Serichim in '/>"/>

SOURCE Creabilis SA
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Combat Medical Systems Awarded $86 Million DOD Contract
2. Remedium Technologies Inc. Awarded $500,000 Phase II NSF SBIR Grant to Test Sprayable Foam for Stopping Traumatic Bleeding
3. CCS Medical Awarded Medicare Contract
4. GE alliance awarded contract to design new plant-based manufacturing facility in Brazil
5. Hadasit Bio-Holdings Flagship Portfolio Company Enlivex Awarded Orphan Drug Status for ApoCell Treatment by the FDA
6. Pharmaceutical Executive Magazines 2013 Drug "Brand of the Year" Awarded to Leading Merck Diabetes Drug Januvia
7. Romark Laboratories Awarded Contract For Late-Stage Development Of New Influenza Drug
8. MEDICOMP Medical Awarded GSA Schedule, Will Supply VA Hospitals
9. Grant Awarded to Study Novel Therapies for Muco-Obstructive Diseases Includes Studies on Cempras Solithromycin (CEM-101) in a Cystic Fibrosis Anti-inflammatory Model
10. Metabolic Solutions Development Company Awarded Funding by The Michael J. Fox Foundation
11. Kalyspo Awarded Best of Ann Arbor SPARK Boot Camp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... , Oct. 31, 2014  Lycera Corp., a ... treat autoimmune disease and cancer, today announced that ... RORgamma agonist product candidates will be presented at ... of Cancer (SITC) being held November 6-9, 2014 ... National Harbor, MD.  The poster, entitled " Novel ...
(Date:10/31/2014)... 31, 2014 Investor-Edge has initiated ... NSPH ), Isis Pharmaceuticals Inc. (NASDAQ: ... ), ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), ... these five companies can be accessed at: http://investor-edge.com/register ... NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow ...
(Date:10/31/2014)... 31, 2014 ThynkWare ( www.thynkware.com ) is ... text and email messages using their thoughts. ... by ThynkWare,s founder, Duane Cash , which is ... This technology allows users to control their devices in ... thought. ThynkWare provides the interface layer between ...
Breaking Medicine Technology:Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5ThynkWare Speech Helps Those with ALS and Locked-In Syndrome Translate Thought to Speech on Their Smartphone Devices 2
... TAMPA, Fla., May 31, 2011 Following through with plans ... has started services in Florida. Currently operating on a fee ... insurance company contracting in the state. IMD Companies anticipates that ... within a short period of time. ABOUT IMD ...
... 2011 HeartSine Technologies, Inc, a world leader ... warranty period to an exclusive 10 years on its popular ... Defibrillator (PAD) for the treatment of ... the fastest growing AED. The life of its Pad-Pak ® ...
Cached Medicine Technology:IMD Companies, Inc. Announces OMI Operations in Florida 2HeartSine® Increases AED System Warranty to Longest in the Industry 2
(Date:10/31/2014)... St. Joseph, Missouri (PRWEB) October 31, 2014 ... prepare for school, one Midwest optometrist feels they may ... vision problems to affect areas like concentration, school performance ... events may be too brief to identify progressive vision ... Options, St. Joseph, Mo., announces a new initiative: The ...
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Obesity increases the ... black and Hispanic women, two new U.S. studies show. ... found being overweight or obese increased the risk for ... women. "We,ve known this for a long time ... also in Hispanic women," study author Esther John, a ...
(Date:10/31/2014)... Santa Barbara, CA (PRWEB) October 31, 2014 ... for holiday shoppers to find affordable but tasteful gifts for ... special 22nd Annual Early Bird Gift Giving Special , ... percent off when they purchase Wine Club Gift membership. ... to take advantage of this special. Besides offering discounts, Gold ...
(Date:10/31/2014)... 2014 Florida Air Academy, the ... in grades 6-12, is taking the lead when ... and concussions, becoming the first high school in ... Post-Concussion Assessment and Cognitive Testing) computerized assessment to ... lawsuit grabs the headlines, and the Centers for ...
(Date:10/31/2014)... 31, 2014 BCC Research ( http://www.bccresearch.com ) ... QUALITY MARKET , the U.S. indoor air quality (IAQ) market ... a compound annual growth rate (CAGR) of 7% over the ... grow at a CAGR of 7.4%. , Since 2012, ... mold, the outbreak of infectious diseases such as bird flu ...
Breaking Medicine News(10 mins):Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Florida Air Academy Tackling Concussions Head-On 2Health News:Florida Air Academy Tackling Concussions Head-On 3Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3
... , FRIDAY, Jan. 14 (HealthDay News) -- Obese ... doctors than obese white patients, a new study finds. ... Public Health also said they were surprised to find that ... to receive weight and exercise counseling than black patients treated ...
... A simple, automated method of tracking E. coli ... potentially contaminated bodies of water or waterways. The technique described ... and Drug Design could reduce the incidence of waterborne ... environmental and health problem. Water related diseases are the leading ...
... COLUMBUS, Ohio A new study by Ohio State ... cancer by combining two kinds of targeted agents, one ... and one that reverses changes that silence genes that ... available and being evaluated individually in clinical trials, the ...
... THURSDAY, Jan. 13 (HealthDay News) -- Home-based dialysis is an ... say. In a new study, researchers evaluated the impact ... the survival of 2,110 adult Canadian patients who had to ... were similar for both groups of patients during the initial ...
... Association today issued a call to action for the public, ... efforts to reduce the amount of sodium (salt) Americans consume ... Journal of the American Heart Association , the association sets ... the general population, which is to consume no more than ...
... , THURSDAY, Jan. 13 (HealthDay News) -- In an unscripted ... Tucson and America" memorial, President Barack Obama said Rep. Gabrielle ... and her husband Mark Kelly at University Medical Center in ... to House Minority Leader Nancy Pelosi (D-Calif.) confirmed that Pelosi, ...
Cached Medicine News:Health News:Is Race a Factor in Obesity Counseling? 2Health News:Speeding up E. coli detection 2Health News:Study provides molecular rationale for combining targeted agents to treat breast cancer 2Health News:Dialysis Options Remain After Kidney Transplant Failure 2Health News:Population-wide reduction in salt consumption recommended 2Health News:Population-wide reduction in salt consumption recommended 3Health News:Giffords Opens Eyes. Like 'Watching a Miracle,' Friends Say 2Health News:Giffords Opens Eyes. Like 'Watching a Miracle,' Friends Say 3
The RC-4000 guarantees precise and efficient multi-diagnostic measurement by combining keratometry, refraction, refraction/keratometry and contact lens base curve measurement....
... Rechargeable, cordless slit-lamp microscope ... purpose , Easy selection of slit ... , Extra-bright halogen lamp light source ... extra ,power pack , Supports digital ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
World's first commercially available vacuum assisted biopsy device for MRI....
Medicine Products: